Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Handshake HNS Oct 18, 2021 0.23 +2.09   
 Harmony ONE Oct 18, 2021 0.23 +1.86   
 Haven Protocol XHV Oct 18, 2021 8.42 +9.22   
 HazeCoin HAZE Oct 18, 2021 0.00 -0.68   
 Hdac HDAC Oct 18, 2021 0.08 +0.08   
 HeartBout HB Oct 18, 2021 0.00 +27.06   
 Hedera Hashgraph HBAR Oct 18, 2021 0.35 -5.09   
 Hedgecoin HEDG Oct 18, 2021 0.88 -0.68   
 Helium HNT Oct 18, 2021 22.71 +5.19   
 HEROcoin PLAY Oct 18, 2021 0.02 +1.65   
 HEX HEX Oct 18, 2021 0.28 -0.61   
 High Performance Blockchain HPB Oct 18, 2021 0.13 -1.99   
 Hive HVN Oct 18, 2021 0.04 +27.35   
 Hive HIVE Oct 18, 2021 0.75 -4.79   
 Holo HOT Oct 18, 2021 0.01 +0.30   
 Homeros HMR Oct 18, 2021 0.04 +0.03   
 HOQU HQX Oct 18, 2021 0.00 -0.68   
 Humaniq HMQ Oct 18, 2021 0.01 -23.00   
 Huobi Pool Token HPT Oct 18, 2021 0.00 +5.15   
 Huobi Token HT Oct 18, 2021 7.53 -1.23   
 Hxro HXRO Oct 18, 2021 0.46 -1.11   
 HYCON HYC Oct 18, 2021 0.00 +0.70   
 HyperCash HC Oct 18, 2021 0.63 -7.75   
 HyperDAO HDAO Oct 18, 2021 0.02 -0.87   
 Hyperion HYN Oct 18, 2021 0.00 +18.75   
 I-House Token IHT Oct 18, 2021 0.00 +0.26   
 ICON Project ICX Oct 18, 2021 1.99 -1.19   
 IDEX IDEX Oct 18, 2021 0.31 -0.49   
 iEx.ec RLC Oct 18, 2021 4.57 +0.90   
 Ignis IGNIS Oct 18, 2021 0.02 -3.70   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Data:


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK